Virax Biolabs Group Ltd SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KVirax Biolabs Group LtdVRAXOct 9

   Virax Biolabs COO departs

   • COO Dr. Nigel McCracken leaves on Dec 23, 2026
   • Received £3,379.50 redundancy payment
   • Clement Monteil named Acting CSO effective Oct 5, 2026
2. ROUTINE6-KVirax Biolabs Group LtdVRAXSep 4

   Foreign issuer report

3. ROUTINE424B5Virax Biolabs Group LtdVRAXSep 4

   Securities offering

4. ROUTINEEFFECTVirax Biolabs Group LtdVRAXSep 4

   Registration declared effective

5. ROUTINEF-3/AVirax Biolabs Group LtdVRAXSep 2

   Securities offering (amended)

6. ROUTINE6-KVirax Biolabs Group LtdVRAXAug 26

   Foreign issuer report

7. ROUTINE6-KVirax Biolabs Group LtdVRAXAug 18

   Foreign issuer report

8. ROUTINE6-KVirax Biolabs Group LtdVRAXJul 31

   Foreign issuer report

9. ROUTINEF-3Virax Biolabs Group LtdVRAXJul 24

   Securities offering

10. ROUTINE6-KVirax Biolabs Group LtdVRAXJul 16

    Foreign issuer report

11. ROUTINE6-KVirax Biolabs Group LtdVRAXJul 10

    Foreign issuer report

12. ROUTINE6-KVirax Biolabs Group LtdVRAXJul 9

    Foreign issuer report

13. ROUTINE6-KVirax Biolabs Group LtdVRAXJun 24

    Foreign issuer report

14. ROUTINE6-KVirax Biolabs Group LtdVRAXJun 12

    Foreign issuer report

15. ROUTINE6-KVirax Biolabs Group LtdVRAXMay 26

    Foreign issuer report

16. ROUTINE6-KVirax Biolabs Group LtdVRAXMay 22

    Foreign issuer report

17. ROUTINESCHEDULE 13G/AVirax Biolabs Group LtdVRAXMay 15

    Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)

    ARMISTICE CAPITAL, LLC, filed by

18. ROUTINE6-KVirax Biolabs Group LtdVRAXApr 14

    Foreign issuer report

19. ROUTINE6-KVirax Biolabs Group LtdVRAXApr 10

    Foreign issuer report

20. ROUTINE3Virax Biolabs Group LtdVRAXMar 31

    Nelson M Haight, new insider at VRAX

    Nelson M Haight, reporting

21. ROUTINE3Virax Biolabs Group LtdVRAXMar 20

    Nigel William McCracken, new insider at VRAX

    Nigel William McCracken, reporting

22. ROUTINE6-KVirax Biolabs Group LtdVRAXMar 18

    Foreign issuer report

23. ROUTINE3Virax Biolabs Group LtdVRAXMar 18

    4 insider filings

    Evan Michael Norton, new insider at VRAX

    Show all 4

    • 3New insider at VRAXMar 18
    • 3New insider at VRAXMar 18
    • 3New insider at VRAXMar 18
    • 3New insider at VRAXMar 18

    Evan Michael Norton, reporting

24. ROUTINESCHEDULE 13GVirax Biolabs Group LtdVRAXFeb 17

    Ownership stake disclosure by ARMISTICE CAPITAL, LLC

    ARMISTICE CAPITAL, LLC, filed by

25. ROUTINE6-KVirax Biolabs Group LtdVRAXJan 30

    Foreign issuer report

26. ROUTINE424B3Virax Biolabs Group LtdVRAXDec 31, 2025

    Securities offering

27. ROUTINEEFFECTVirax Biolabs Group LtdVRAXDec 31, 2025

    Registration declared effective

28. ROUTINEF-3Virax Biolabs Group LtdVRAXDec 18, 2025

    Securities offering

29. ROUTINEDVirax Biolabs Group LtdVRAXDec 18, 2025

    Private placement notice

30. ROUTINE6-KVirax Biolabs Group LtdVRAXDec 4, 2025

    Foreign issuer report

31. ROUTINE6-KVirax Biolabs Group LtdVRAXDec 2, 2025

    Foreign issuer report

Older filings on EDGAR